Jonathan Chung to Receptor, ErbB-2
This is a "connection" page, showing publications Jonathan Chung has written about Receptor, ErbB-2.
Connection Strength
0.310
-
Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions. BJU Int. 2020 05; 125(5):739-746.
Score: 0.153
-
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib. J Thorac Oncol. 2017 03; 12(3):446-457.
Score: 0.122
-
RET rearrangements are actionable alterations in breast cancer. Nat Commun. 2018 11 16; 9(1):4821.
Score: 0.035